期刊文献+

苯那普利和氯沙坦联合治疗老年顽固性充血性心力衰竭70例临床研究 被引量:1

Effects of combination therapy with benazepril and losartan on senile patients with congestive heart failure
下载PDF
导出
摘要 目的 :观察苯那普利和氯沙坦联合治疗老年顽固性充血性心力衰竭的疗效。方法 :对 70例老年顽固性充血性心力衰竭患者在常规抗心力衰竭治疗无效的情况下 ,停用血管扩张剂 ,3d之后加用苯那普利和氯沙坦联合治疗。观察心功能改善情况及药物的不良反应。结果 :苯那普利和氯沙坦联合治疗老年顽固性充血性心力衰竭总有效率为80 .0 %。未发生严重的不良反应。结论 :苯那普利和氯沙坦联合治疗老年顽固性充血性心力衰竭有效 ,具有良好的安全性和耐受性。 Objective:To observe the effects of combination therapy with benazepril and losartan on senile patients with congestive heart failure.Methods:Benazepril and losartan were used on 70 cases senile patients with congestive heart failure after regulary treatment to heart failure.The improving degree of heart function and adverse effects of drug were observed.Results:The total effective rate of benazepril and losartan on treating congestive heart failure amounted to 80.0 %.No severe adverse effects were found.Conclusion:It was an effective method that the combination of benazepril and losartan were used to treat congestive heart failure.This method had excellent safety and tolerance.
作者 杜爱英
出处 《临床医药实践》 2004年第10期739-740,共2页 Proceeding of Clinical Medicine
关键词 顽固性充血性心力衰竭 老年 血管紧张素转换酶抑制药 血管紧张素Ⅱ受体拮抗剂 congestive heart failure senile Angiotensin converting enzyme inhibition Angiotensin Ⅱantagonist
  • 相关文献

参考文献3

二级参考文献11

  • 1郭志凌,国外医学心血管疾病分册,1996年,1期,28页 被引量:1
  • 2Hamroff G,Blaufarb I,Mancini D,et al.Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treat with angiotensin-converting enzyme inhibitors for heart failure[].Journal of Cardiovascular Pharmacology.1997 被引量:1
  • 3Krombach RS,Clair MJ,Hendrick JW,et al.Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns[].Cardiovascular Research.1998 被引量:1
  • 4Baruch L,Anand I,Cohen IS,et al.Augmented short-and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patient with heart failure[].Circulation.1999 被引量:1
  • 5Lang RM,Elkayam U,Yellen LG,et al.Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure[].Journal of the American College of Cardiology.1997 被引量:1
  • 6McKelvie RA,Yusuf S,Pericak D,et al.Comparison of candesartan,enalapril, and their combination in congestive heart failure[].Circulation.1999 被引量:1
  • 7Hamroff G,Blaufarb I,Mancini D,et al.Maximally recommended doses of ACE inhibitors do not completely prevent ACE-mediated formation of Ang II in CHF[].Circulation.2000 被引量:1
  • 8Dickstein K,Chang P,Willenheimer R,et al.Comparison of the effects of Losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure[].Journal of the American College of Cardiology.1995 被引量:1
  • 9Crozier I,Ikram H,Awan N,et al.Losartan in heart failure:hemodynamic effects and tolerability[].Circulation.1995 被引量:1
  • 10Cohn JN,Tognoni G.A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure[].The New England Journal of Medicine.2001 被引量:1

共引文献62

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部